 Investing in Teladoc Health, Inc. is a contrarian call. Sentiment is deep-negative. The firm faces a lot of competition, but actually enjoys even more competitive advantages. The Teladoc top line has decelerated, but the firm remains a high growth candidate. Bottom line improvements create the conditions for a major rerating of both the business and its stock. 